candesartan has been researched along with Allodynia in 1 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with candesartan and C21 was started on day 1, before VCR treatment, and continued until day 7." | 1.48 | Neuroprotective effect of angiotensin II type 2 receptor stimulation in vincristine-induced mechanical allodynia. ( Bessaguet, F; Bouchenaki, H; Danigo, A; Demiot, C; Desmoulière, A; Duchesne, M; Magy, L; Richard, L; Sturtz, F, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bessaguet, F | 1 |
| Danigo, A | 1 |
| Bouchenaki, H | 1 |
| Duchesne, M | 1 |
| Magy, L | 1 |
| Richard, L | 1 |
| Sturtz, F | 1 |
| Desmoulière, A | 1 |
| Demiot, C | 1 |
1 other study available for candesartan and Allodynia
| Article | Year |
|---|---|
Neuroprotective effect of angiotensin II type 2 receptor stimulation in vincristine-induced mechanical allodynia.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Antineopl | 2018 |